Titration — the gradual step-up in dose over weeks and months — is the foundation of safe, effective GLP-1 treatment. Rush it and side effects become severe. Follow it properly and most people tolerate escalation well. The schedules below are based on the MHRA-approved Summary of Product Characteristics for each medication, updated to reflect the Wegovy 7.2mg addition approved in January 2026.

Mounjaro (tirzepatide) titration schedule

Mounjaro has six dose increments — more than any other GLP-1 medication currently licensed in the UK. Every patient starts at 2.5mg regardless of their weight or treatment goals. The minimum time at each dose before escalating is four weeks, though staying longer is always an option.

Mounjaro — dose by month
Month
Dose
Pen colour
Notes
1
2.5mg
Grey
Starting dose — for initiation only, not therapeutic
2
5mg
Red
First therapeutic dose — most people see appetite change
3
7.5mg
Yellow
Often where meaningful weight loss accelerates
4
10mg
Blue
Many people find their maintenance dose here
5
12.5mg
Purple
Penultimate step — only escalate if needed
6+
15mg
Teal
Maximum dose — not required for everyone

Each Mounjaro pen contains 4 doses — one pen per month at standard weekly dosing. The starting dose of 2.5mg is an initiation dose only; it's not intended to produce significant weight loss but to let your body adjust to the mechanism before increasing.

Wegovy (semaglutide) titration schedule

Wegovy has five steps to the standard 2.4mg maintenance dose, taking approximately 16 weeks. From January 2026, two additional doses — 3.6mg and 7.2mg — are licensed in the UK for patients who have completed standard titration and tolerated 2.4mg. The 7.2mg is not a starting dose and should only be considered after adequate time at 2.4mg.

Wegovy — dose by month
Month
Dose
Pen colour
Notes
1
0.25mg
Yellow
Starting dose — initiation only
2
0.5mg
Yellow
Mild appetite suppression begins for most
3
1mg
Pink
Noticeable appetite change for most patients
4
1.7mg
Blue
Strong appetite suppression; GI effects often peak here
5+
2.4mg
Grey
Standard maintenance dose
7+
3.6mg New
Teal
Optional extended dose — only after ≥8wks on 2.4mg
9+
7.2mg New 2026
Teal
Maximum dose — for plateau at 2.4mg only

On the 7.2mg Wegovy dose: It was MHRA-approved in January 2026 and is now available through private providers, though not universally. It is only appropriate for patients who have been on 2.4mg for at least 8 weeks, are tolerating it well, and haven't achieved their goal weight. It is not a replacement for 2.4mg as a standard maintenance dose — it's an extension for patients who have plateaued.

Side-by-side comparison

Factor Mounjaro (tirzepatide) Wegovy (semaglutide)
Starting dose 2.5mg 0.25mg
Standard maintenance dose 10–15mg (individual) 2.4mg (7.2mg optional)
Number of dose steps 6 (to 15mg) 5 to 2.4mg; 7 to 7.2mg
Weeks to standard maintenance ~20 weeks minimum ~16 weeks minimum
Minimum time at each dose 4 weeks 4 weeks
Can you slow down? Yes — stay longer at any step Yes — stay longer at any step
Can you go back down? Yes — dose reduction is supported Yes — dose reduction is supported
Doses per pen 4 4
Pen mechanism KwikPen (click system) FlexTouch (dial and press)

What to expect at each stage

The experience at each stage is broadly predictable — though how any individual responds varies considerably. Here's what most people find:

Month 1
Mounjaro 2.5mg · Wegovy 0.25mg
Most people notice little to nothing. Some mild nausea the day after injection. Appetite change is minimal at this dose. This is by design — the first month is purely about introducing the medication to your system. Don't judge effectiveness here.
Month 2
Mounjaro 5mg · Wegovy 0.5mg
Appetite suppression begins to become noticeable for most people. Portions that felt insufficient before start feeling adequate. Food noise — the constant mental preoccupation with eating — often quietens. GI side effects typically increase, especially in the days after injection day.
Month 3
Mounjaro 7.5mg · Wegovy 1mg
This is when most people see meaningful weight loss begin. The 3-month check is here — if you've lost at least 5% of starting weight, the medication is working for you. Side effects typically improve at a stable dose; they tend to spike with each escalation.
Month 4–5
Mounjaro 10–12.5mg · Wegovy 1.7mg
Strong therapeutic range. Many people find their effective maintenance dose here and don't need to go further. GI side effects often peak during the 1.7mg Wegovy step — this is the most common point where people consider slowing down or stepping back.
Month 5–6+
Mounjaro 15mg · Wegovy 2.4mg
Maximum standard dose. Not everyone needs to get here. Weight loss typically slows as you approach your body's new set point. This is maintenance territory for most — the dose that holds results, not necessarily the dose that produces the fastest loss.
Month 7–9+
Wegovy 3.6mg → 7.2mg only
For patients who have plateaued at 2.4mg and haven't reached their goal. Only available since January 2026. The STEP UP trial showed average 20.7% weight loss at 7.2mg — comparable to Mounjaro's headline figure. Discuss with your prescriber, not all providers offer this yet.

When to slow down — and how

The four-week minimum between dose increases is a floor, not a target. The SmPC for both medications explicitly supports remaining at any dose for longer than four weeks if tolerability requires it. There's no clinical penalty for a slower titration — and there's a meaningful benefit in terms of side effects and adherence.

Long-term adherence matters more than reaching the maximum dose quickly. A person who stays on 7.5mg Mounjaro comfortably for a year will typically achieve better outcomes than someone who pushes to 15mg, develops severe nausea, and stops after three months.

Signs you should pause before escalating:

  • Nausea that persists beyond 4–5 days after injection day, rather than settling in 1–2 days
  • Vomiting more than once or twice, or persistent inability to eat normally
  • Significant disruption to daily life — work, social commitments, sleep
  • Weight loss proceeding well at your current dose — no clinical reason to increase

Dose reduction is always an option. Both medications support stepping back to the previous dose if the current one isn't tolerable. This is not a failure — it's appropriate clinical management. Tell your prescriber; don't just reduce unilaterally without logging it.

Finding your maintenance dose

Your maintenance dose is the lowest dose that produces adequate appetite suppression and continued weight loss — or, once at goal weight, holds your results. It's individual, and it may be well below the maximum licensed dose.

A meaningful proportion of people on Mounjaro find their effective maintenance dose is 7.5mg or 10mg rather than 15mg. On Wegovy, some find 1.7mg or even 1mg is sufficient. The data from SURMOUNT and STEP trials focused on maximum doses because trials aim to demonstrate maximum efficacy — but real-world prescribing is more nuanced.

The right question to ask at every review is not "should I go up?" but "is my current dose working?" If the answer is yes, there's no compelling reason to escalate — and good reasons not to, including cost, side effects, and simplicity.

Managing side effects during escalation

GI side effects — nausea, constipation, diarrhoea, bloating — are most pronounced at two points: when you first start the medication, and after each dose increase. They typically settle within one to two weeks at a stable dose. If they don't, that's a signal the dose increase was too fast.

What actually helps during escalation:

  • Eat smaller meals — the medication slows gastric emptying; a large meal on top of that is uncomfortable. Smaller, more frequent eating works better during titration
  • Avoid fatty, rich, or greasy foods — particularly in the 24–48 hours after injection. They're significantly harder to tolerate during escalation
  • Time your injection strategically — many people inject before bed so the peak side-effect window (6–12 hours post-injection) happens overnight
  • Stay hydrated — constipation is common and dehydration compounds it significantly. Fibre intake also helps
  • Don't push through severe nausea — staying at your current dose an extra four weeks costs nothing and may resolve the problem entirely

Contact your prescriber or 111 immediately for severe or persistent abdominal pain — this can indicate pancreatitis. Also seek help for signs of dehydration from persistent vomiting or diarrhoea (dizziness, dark urine, inability to keep fluids down). These are rare but serious; don't wait and see with either.

Provider support during titration varies enormously. Some include clinical check-ins at each dose step; others just dispatch medication. Use cleardose to compare what's included.

Compare providers →

Common questions

Do I have to reach the maximum dose?
No. The maximum dose exists because it produces the greatest average weight loss in trials. But if you're achieving your goals at a lower dose, escalating further adds cost, side effects, and complexity without clear benefit. Many people find their effective maintenance dose significantly below the maximum. Your prescriber should support staying at whatever dose is working rather than pushing escalation for its own sake.
What if I miss an injection during titration?
For Mounjaro: if fewer than 4 days (96 hours) have passed since your scheduled dose, take it as soon as you remember and continue your regular schedule. If more than 4 days have passed, skip that dose and resume on your next scheduled day. For Wegovy, the window is 5 days. Don't take two doses to compensate. A single missed dose during titration is unlikely to significantly affect your overall trajectory — the medications have long half-lives.
Can I go backwards — reduce to a previous dose?
Yes, and this is clinically supported. If a dose increase produces intolerable side effects, stepping back to the previous dose is appropriate. Tell your prescriber so it's logged correctly. You can then try escalating again after a longer period at the lower dose, or decide to stay there if it's producing adequate results.
Can I change my injection day during titration?
Yes. If you need to move your injection day — travel, events, schedule changes — you can adjust as long as you maintain at least 3 days between doses. Taking a dose one day early or late is unlikely to cause problems given the medications' long half-lives. If you need to change your injection day permanently, simply shift it by taking one dose at the new time, then resuming weekly from there. Don't take two doses within 3 days.
Is there a difference in how quickly people titrate between Mounjaro and Wegovy?
Wegovy reaches its standard maintenance dose about one month faster than Mounjaro (16 weeks versus 20 weeks minimum). This is because Mounjaro has an additional dose step — 12.5mg sits between 10mg and 15mg. However, real-world titration rates are broadly similar because both medications allow (and often require) staying at doses longer than the minimum four weeks. Many people take 6–9 months to reach their maintenance dose on either medication.
Can I get the Wegovy 7.2mg dose on the NHS?
NHS access to Wegovy for weight loss remains extremely limited — typically through specialist Tier 3 weight management services with long waiting times. The 7.2mg dose is very unlikely to be available through NHS channels in the near term. It is available through private providers, though not universally — check availability when comparing providers on cleardose.